Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate ...

Russell W. Jenkins, MD, Ph.D., a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...

ARKANSAS, USA — UAMS has received a five-year, $2.9 million research grant from the National Institutes of Health based on a ...

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from ...

Oral vaccines encounter several challenges, here research explore developing and testing dmLT and saponin combination ...

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...

The largest documented outbreak of blastomycosis in the United States was reported at a paper mill in Michigan in 2022-2023.

DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated by its ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.